Nektar Therapeutics releases positive results from its trial for the treatment of alopecia areata.

Share on Pinterest FDA approves Olumiant for the treatment of severe alopecia. Image credit: Wirestock Creators/Shutterstock. There are several forms of alopecia, including alopecia areata, an ...

Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on development of novel immunology therapies, today announced new results from a blinded 16-week treatment extension ...

Detailed price information for Nektar Therapeutics (NKTR-Q) from The Globe and Mail including charting and trades.

Traction alopecia is a type of hair loss caused by hairstyles or other things that pull on your hair. This is most often due to wearing tight hairstyles, but it can also come from wearing caps or ...

Shares of Nektar Therapeutics surged Monday after the company reported promising results for its experimental alopecia treatment.

Patients with ophiasis may be categorized into 3 distinct subtypes that can guide early intervention and stratify treatment.

Nektar Therapeutics (NASDAQ:NKTR) presented 52-week top-line results from a 16-week blinded treatment extension of its Phase ...

Before and after images of four study participants who recieved 36 weeks of treatment for severe alopecia areata with the drug baricitinib. Brett King/Yale School of Medicine The U.S. Food and Drug ...

Alopecia is a condition that causes hair loss. It’s an autoimmune condition that damages hair follicles. Alopecia can affect hair on your scalp, eyebrows, or anywhere on your body. Hair may come out ...

The Oscar slap that overshadowed the Academy Awards ceremony was sparked by a joke about Jada Pinkett Smith’s lack of hair – with husband Will Smith objecting violently to comedian Chris Rock mocking ...